Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Post-exposure prophylaxis with rVSV-ZEBOV following exposure to a patient with Ebola virus disease relapse in the UK: an operational, safety and immunogenicity report.

Davis C, Tipton T, Sabir S, Aitken C, Bennett S, Becker S, Evans T, Fehling SK, Gunson R, Hall Y, Jackson C, Johanssen I, Kieny MP, McMenamin J, Spence E, Strecker T, Sykes C, Templeton K, Thorburn F, Peters E, Henao Restrepo AM, White B, Zambon M, Carroll MW, Thomson EC.

Clin Infect Dis. 2019 Nov 30. pii: ciz1165. doi: 10.1093/cid/ciz1165. [Epub ahead of print]

PMID:
31784751
2.

Design of vaccine efficacy trials during public health emergencies.

Dean NE, Gsell PS, Brookmeyer R, De Gruttola V, Donnelly CA, Halloran ME, Jasseh M, Nason M, Riveros X, Watson CH, Henao-Restrepo AM, Longini IM.

Sci Transl Med. 2019 Jul 3;11(499). pii: eaat0360. doi: 10.1126/scitranslmed.aat0360. Review.

3.

An online decision tree for vaccine efficacy trial design during infectious disease epidemics: The InterVax-Tool.

Bellan SE, Eggo RM, Gsell PS, Kucharski AJ, Dean NE, Donohue R, Zook M, Edmunds WJ, Odhiambo F, Longini IM Jr, Brisson M, Mahon BE, Henao-Restrepo AM.

Vaccine. 2019 Jul 18;37(31):4376-4381. doi: 10.1016/j.vaccine.2019.06.019. Epub 2019 Jun 24.

4.

Determinants of Transmission Risk During the Late Stage of the West African Ebola Epidemic.

Robert A, Edmunds WJ, Watson CH, Henao-Restrepo AM, Gsell PS, Williamson E, Longini IM, Sakoba K, Kucharski AJ, Touré A, Nadlaou SD, Diallo B, Barry MS, Fofana TO, Camara L, Kaba IL, Sylla L, Diaby ML, Soumah O, Diallo A, Niare A, Diallo A, Eggo RM.

Am J Epidemiol. 2019 Jul 1;188(7):1319-1327. doi: 10.1093/aje/kwz090.

5.

Global Review of the Age Distribution of Rotavirus Disease in Children Aged <5 Years Before the Introduction of Rotavirus Vaccination.

Hasso-Agopsowicz M, Ladva CN, Lopman B, Sanderson C, Cohen AL, Tate JE, Riveros X, Henao-Restrepo AM, Clark A; Global Rotavirus Surveillance Network and Rotavirus Age Study Collaborators .

Clin Infect Dis. 2019 Aug 30;69(6):1071-1078. doi: 10.1093/cid/ciz060.

6.

Questionable efficacy of the rVSV-ZEBOV Ebola vaccine - Authors' reply.

Longini IM, Røttingen JA, Kieny MP, Edmunds WJ, Henao-Restrepo AM.

Lancet. 2018 Mar 17;391(10125):1021-1022. doi: 10.1016/S0140-6736(18)30559-2. Epub 2018 Mar 15. No abstract available.

PMID:
29565012
7.

Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.

Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Nadlaou SD, Dean NE, Diallo A, Diallo A, Honora DA, Doumbia M, Enwere G, Higgs ES, Mauget T, Mory D, Riveros X, Oumar FT, Fallah M, Toure A, Vicari AS, Longini IM, Edmunds WJ, Henao-Restrepo AM, Kieny MP, Kéïta S.

Lancet Infect Dis. 2017 Dec;17(12):1276-1284. doi: 10.1016/S1473-3099(17)30541-8. Epub 2017 Oct 9. Erratum in: Lancet Infect Dis. 2017 Dec;17 (12 ):1232.

8.

Two-dose schedules for human papillomavirus vaccine: Systematic review and meta-analysis.

D'Addario M, Redmond S, Scott P, Egli-Gany D, Riveros-Balta AX, Henao Restrepo AM, Low N.

Vaccine. 2017 May 19;35(22):2892-2901. doi: 10.1016/j.vaccine.2017.03.096. Epub 2017 Apr 25. Review.

9.

Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!).

Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M, Carroll MW, Dean NE, Diatta I, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Gsell PS, Hossmann S, Watle SV, Kondé MK, Kéïta S, Kone S, Kuisma E, Levine MM, Mandal S, Mauget T, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Røttingen JA, Kieny MP.

Lancet. 2017 Feb 4;389(10068):505-518. doi: 10.1016/S0140-6736(16)32621-6. Epub 2016 Dec 23. Erratum in: Lancet. 2017 Feb 4;389(10068):504. Lancet. 2017 Feb 4;389(10068):504.

10.

On a path to accelerate access to Ebola vaccines: The WHO's research and development efforts during the 2014-2016 Ebola epidemic in West Africa.

Henao-Restrepo AM, Preziosi MP, Wood D, Moorthy V, Kieny MP; WHO Ebola Research, Development Team.

Curr Opin Virol. 2016 Apr;17:138-144. doi: 10.1016/j.coviro.2016.03.008. Epub 2016 May 12. Review.

11.

Changes in the primary outcome in Ebola vaccine trial--Authors' reply.

Kieny MP, Longini IM, Henao-Restrepo AM, Watson CH, Egger M, Edmunds WJ.

Lancet. 2016 Apr 9;387(10027):1509-1510. doi: 10.1016/S0140-6736(16)00686-3. Epub 2016 Apr 7. No abstract available.

PMID:
27115974
12.

Ebola vaccination - Authors' reply.

Longini IM, Egger M, Dean NE, Edmunds WJ, Henao-Restrepo AM; study steering group.

Lancet. 2015 Dec 19;386(10012):2480. doi: 10.1016/S0140-6736(15)00951-4. Epub 2015 Dec 18. No abstract available.

PMID:
26738716
13.

Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial.

Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A, Carroll MW, Doumbia M, Draguez B, Duraffour S, Enwere G, Grais R, Gunther S, Hossmann S, Kondé MK, Kone S, Kuisma E, Levine MM, Mandal S, Norheim G, Riveros X, Soumah A, Trelle S, Vicari AS, Watson CH, Kéïta S, Kieny MP, Røttingen JA.

Lancet. 2015 Aug 29;386(9996):857-66. doi: 10.1016/S0140-6736(15)61117-5. Epub 2015 Aug 3.

PMID:
26248676
14.

A randomized, controlled trial of an aerosolized vaccine against measles.

Low N, Bavdekar A, Jeyaseelan L, Hirve S, Ramanathan K, Andrews NJ, Shaikh N, Jadi RS, Rajagopal A, Brown KE, Brown D, Fink JB, John O, Scott P, Riveros-Balta AX, Greco M, Dhere R, Kulkarni PS, Henao Restrepo AM.

N Engl J Med. 2015 Apr 16;372(16):1519-29. doi: 10.1056/NEJMoa1407417.

15.

Case based measles surveillance in Pune: evidence to guide current and future measles control and elimination efforts in India.

Bose AS, Jafari H, Sosler S, Narula AP, Kulkarni VM, Ramamurty N, Oommen J, Jadi RS, Banpel RV, Henao-Restrepo AM.

PLoS One. 2014 Oct 7;9(10):e108786. doi: 10.1371/journal.pone.0108786. eCollection 2014.

16.

Ebola vaccine--an urgent international priority.

Kanapathipillai R, Henao Restrepo AM, Fast P, Wood D, Dye C, Kieny MP, Moorthy V.

N Engl J Med. 2014 Dec 11;371(24):2249-51. doi: 10.1056/NEJMp1412166. Epub 2014 Oct 7. No abstract available.

17.

Standard method for detecting upper respiratory carriage of Streptococcus pneumoniae: updated recommendations from the World Health Organization Pneumococcal Carriage Working Group.

Satzke C, Turner P, Virolainen-Julkunen A, Adrian PV, Antonio M, Hare KM, Henao-Restrepo AM, Leach AJ, Klugman KP, Porter BD, Sá-Leão R, Scott JA, Nohynek H, O'Brien KL; WHO Pneumococcal Carriage Working Group.

Vaccine. 2013 Dec 17;32(1):165-79. doi: 10.1016/j.vaccine.2013.08.062. Review.

18.

Group A streptococcal vaccines: paving a path for accelerated development.

Dale JB, Fischetti VA, Carapetis JR, Steer AC, Sow S, Kumar R, Mayosi BM, Rubin FA, Mulholland K, Hombach JM, Schödel F, Henao-Restrepo AM.

Vaccine. 2013 Apr 18;31 Suppl 2:B216-22. doi: 10.1016/j.vaccine.2012.09.045. Review.

PMID:
23598485
19.

Comparing pneumococcal conjugate vaccine schedules in infancy.

Low N, Scott P, Henao Restrepo AM.

Vaccine. 2012 Nov 26;30(50):7145. doi: 10.1016/j.vaccine.2012.01.019. Epub 2012 Feb 10. No abstract available.

PMID:
22326900
20.

Measles aerosol vaccination.

Valdespino-Gómez JL, de Lourdes Garcia-Garcia M, Fernandez-de-Castro J, Henao-Restrepo AM, Bennett J, Sepulveda-Amor J.

Curr Top Microbiol Immunol. 2006;304:165-93. Review.

PMID:
16989270
21.

Global measles elimination efforts: the significance of measles elimination in the United States.

Strebel PM, Henao-Restrepo AM, Hoekstra E, Olive JM, Papania MJ, Cochi SL.

J Infect Dis. 2004 May 1;189 Suppl 1:S251-7.

PMID:
15106119
22.

Determining measles-containing vaccine demand and supply: an imperative to support measles mortality reduction efforts.

Costa A, Henao-Restrepo AM, Marie Hall S, Jarrett S, Hoekstra EJ.

J Infect Dis. 2003 May 15;187 Suppl 1:S22-8. Review.

PMID:
12721888
23.

Experience in global measles control, 1990-2001.

Henao-Restrepo AM, Strebel P, John Hoekstra E, Birmingham M, Bilous J.

J Infect Dis. 2003 May 15;187 Suppl 1:S15-21.

PMID:
12721887
24.

Measles vaccination in Africa: by how much could routine coverage be improved?

Edmunds WJ, Gay NJ, Henao Restrepo AM, Olivé JM, Bele O.

Vaccine. 2001 Oct 12;20(1-2):16-8.

PMID:
11567740

Supplemental Content

Loading ...
Support Center